Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HandClens
- Development stage
- Unknown
- Lead developer
- Pacific World
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
HandClens is a branded, alcohol-free, non-flammable **foaming hand sanitizer** primarily formulated with **0.13% benzalkonium chloride** as its active ingredient. It is designed to decrease bacteria on the skin, providing antiseptic action and germ-killing effectiveness. It is produced as a foam and often formulated with skin-conditioning agents such as allantoin. The primary indication is hand sanitizing to reduce bacteria and prevent transmission of infectious diseases in scenarios where soap and water are not available[2][3][5][7].
- Brand names
- HandClens
- Other names
- Woodwards HandClens Foaming SanitizerHandClens Foaming Sanitizer & LotionWoodward's HandClens
Beyond the preview
Go deeper on HandClens.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HandClens.